Diversified Process LCI Corporation specializes in liquids and solids processing for the chemical and pharmaceutical sectors, presenting cross-sell opportunities between evaporation, drying, filtration, extrusion, spheronization, feeding, and pelleting technology to process manufacturers and contract manufacturers.

Pharma Granulation The Dome Ex continuous wet granulation system launched in 2020 highlights a proven capability in pharmaceutical manufacturing, suggesting potential sales opportunities with pharma producers seeking scalable wet granulation solutions and process modernization.

Nederman Network Being part of the Nederman Group since 2012 provides a broader corporate backing and potential for integrated sustainability and safety offerings, enabling bundled solutions and cross-selling with Nederman’s existing industrial hygiene and filtration portfolios.

Mid-Mized Growth With 51-200 employees and revenue in the $25M-$50M range, LCI sits in a mid-market niche, indicating a responsiveness to targeted, high-value equipment upgrades, retrofit projects, and service contracts for mid-sized process facilities.

Strategic Partnerships Past collaboration with Buss-SMS-Canzler and ongoing product launches imply openness to alliance-based sales, co-development opportunities, and channel partnerships to penetrate European and global process industries.